This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Oct;260(7):507-8.

doi: 10.1007/s00406-010-0154-6.

Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy

P Falkai, H-J Möller

PMID: 20922543
PMCID: PMC2953629
DOI: 10.1007/s00406-010-0154-6

Editorial

Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy

P Falkai et al. Eur Arch Psychiatry Clin Neurosci. 2010 Oct.

. 2010 Oct;260(7):507-8.

doi: 10.1007/s00406-010-0154-6.

Authors

P Falkai, H-J Möller

PMID: 20922543
PMCID: PMC2953629
DOI: 10.1007/s00406-010-0154-6

No abstract available

PubMed Disclaimer

Similar articles

A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
Becker RC. Becker RC. J Thromb Thrombolysis. 2008 Jun;25(3):300-2. doi: 10.1007/s11239-008-0231-0. Epub 2008 May 11. J Thromb Thrombolysis. 2008. PMID: 18470653 No abstract available.
Methodological issues in pharmacotherapy research in older adults.
Orwig D, Rickles NM, Martin LG. Orwig D, et al. Am J Geriatr Pharmacother. 2011 Jun;9(3):173-89. doi: 10.1016/j.amjopharm.2011.04.008. Am J Geriatr Pharmacother. 2011. PMID: 21636042 Review.
The drug-eluting stent information gap.
Yock CA, Yock PG. Yock CA, et al. Am Heart Hosp J. 2004 Winter;2(1):21-5. doi: 10.1111/j.1541-9215.2004.03320.x. Am Heart Hosp J. 2004. PMID: 15604835 Review.
Personalized pharmacotherapy: genotypes, biomarkers, and beyond.
Gurwitz D, Lunshof JE. Gurwitz D, et al. Clin Pharmacol Ther. 2009 Feb;85(2):142. doi: 10.1038/clpt.2008.228. Epub 2008 Nov 12. Clin Pharmacol Ther. 2009. PMID: 19005463 No abstract available.
Clinical study designs and patient selection methods based on genomic biomarkers: Points-to-consider documents.
Tohkin M, Saito Y, Yagi S, Asano K, Maekawa K, Osabe M, Iida S, Miyata N. Tohkin M, et al. Drug Metab Pharmacokinet. 2020 Apr;35(2):187-190. doi: 10.1016/j.dmpk.2020.01.003. Epub 2020 Jan 18. Drug Metab Pharmacokinet. 2020. PMID: 32007355 Review.

See all similar articles

References

1. Martins-de-Souza D (2010) Is the word ‘biomarker’ being properly used by proteomics research in neuroscience? Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0105-2 - PMC - PubMed
1. Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K et al. (2010) Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0098-x - PubMed
1. Zilles D, Gruber E, Falkai P, Gruber O (2010) Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0107-0 - PMC - PubMed
1. Eker C, Kitis O, Taneli F, Eker OD, Ozan E, Yucel K, Coburn K, Gonul AS (2010) Correlation of serum BDNF levels with hippocampal volumes in first episode, medication-free depressed patients. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0110-5 - PubMed
1. Moraes C, Pinto JA Jr, Lopes MA, Litvoc J, Bottino CM (2010) Impact of sociodemographic and health variables on mini-mental state examination in a community-based sample of older people. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0104-3 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources